Biofilm formation increases treatment failure in Staphylococcus epidermidis device-related osteomyelitis of the lower extremity in human patients

Journal of Orthopaedic Research

Volumn 34, Issue 11, 2016, Pages 1905-1913

  Morgenstern, Mario ^a,b   Post, Virginia ^b   Erichsen, Christoph ^a,b   Hungerer, Sven ^a   Bühren, Volker ^a   Militz, Matthias ^a   Richards, R Geoff ^b   Moriarty, T Fintan ^b  

^a BG UNFALLKLINIK MURNAU   (Germany)

^b AO RESEARCH INSTITUTE   (Switzerland)

Author keywords

antibiotic resistance; biofilm formation; orthopaedic device related infections; risk factor; Staphylococcus epidermidis

Indexed keywords

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; BIOFILM; DISEASE COURSE; FEMALE; HUMAN; IMMUNE DEFICIENCY; LOWER LIMB; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NONHUMAN; ORTHOPEDIC EQUIPMENT; OSTEOMYELITIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK FACTOR; STAPHYLOCOCCUS EPIDERMIDIS; TREATMENT FAILURE; AGED; MICROBIOLOGY; PATHOGENICITY; PENICILLIN RESISTANCE; PHENOTYPE; PHYSIOLOGY; PROSPECTIVE STUDY; PROSTHESIS-RELATED INFECTIONS; RECURRENT DISEASE;

ANTIINFECTIVE AGENT;

ADULT; AGED; ANTI-INFECTIVE AGENTS; BIOFILMS; FEMALE; HUMANS; MALE; METHICILLIN RESISTANCE; MIDDLE AGED; PHENOTYPE; PROSPECTIVE STUDIES; PROSTHESIS-RELATED INFECTIONS; RECURRENCE; STAPHYLOCOCCUS EPIDERMIDIS; TREATMENT FAILURE;

EID: 84970966294     PISSN: 07360266     EISSN: 1554527X     Source Type: Journal    
DOI: 10.1002/jor.23218     Document Type: Article

References (33)

1. Zimmerli W, Trampuz A, Ochsner PE. 2004. Prosthetic-joint infections. N Engl J Med 351:1645–1654.
2. Donlan RM. 2001. Biofilm formation: a clinically relevant microbiological process. Clin Infect Dis 33:1387–1392.
3. Wimmer MD, Randau TM, Petersdorf S, et al. 2013. Evaluation of an interdisciplinary therapy algorithm in patients with prosthetic joint infections. Int Orthop 37:2271–2278.
4. Martel-Laferriere V, Laflamme P, Ghannoum M, et al. 2013. Treatment of prosthetic joint infections: validation of a surgical algorithm and proposal of a simplified alternative. J Arthroplasty 28:395–400.
5. Falagas ME, Kapaskelis AM, Kouranos VD, et al. 2009. Outcome of antimicrobial therapy in documented biofilm-associated infections: a review of the available clinical evidence. Drugs 69:1351–1361.
6. Costerton JW, Stewart PS, Greenberg EP. 1999. Bacterial biofilms: a common cause of persistent infections. Science 284:1318–1322.
7. Trampuz A, Zimmerli W. 2005. Prosthetic joint infections: update in diagnosis and treatment. Swiss Med Wkly 135:243–251.
8. Trampuz A, Zimmerli W. 2006. Diagnosis and treatment of infections associated with fracture-fixation devices. Injury 37 Suppl 2:S59–S66.
9. Schafer P, Fink B, Sandow D, et al. 2008. Prolonged bacterial culture to identify late periprosthetic joint infection: a promising strategy. Clin Infect Dis 47:1403–1409.
10. Otto M. 2012. Molecular basis of Staphylococcus epidermidis infections. Semin Immunopathol 34:201–214.
11. Waters EM, McCarthy H, Hogan S, et al. 2014. Rapid quantitative and qualitative analysis of biofilm production by Staphylococcus epidermidis under static growth conditions. Methods Mol Biol 1106:157–166.
12. Hellmark B, Soderquist B, Unemo M, et al. 2013. Comparison of Staphylococcus epidermidis isolated from prosthetic joint infections and commensal isolates in regard to antibiotic susceptibility, agr type, biofilm production, and epidemiology. Int J Med Microbiol 303:32–39.
13. Schwotzer N, Wahl P, Fracheboud D, et al. 2014. Optimal culture incubation time in orthopedic device-associated infections: a retrospective analysis of prolonged 14-day incubation. J Clin Microbiol 52:61–66.
14. Charlson ME, Pompei P, Ales KL, et al. 1987. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383.
15. Teterycz D, Ferry T, Lew D, et al. 2010. Outcome of orthopedic implant infections due to different staphylococci. Int J Infect Dis 14:e913–e918.
16. Osmon DR, Berbari EF, Berendt AR, et al. 2013. Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 56:e1–25.
17. Tande AJ, Patel R. 2014. Prosthetic joint infection. Clin Microbiol Rev 27:302–345.
18. Campbell KA, Stein S, Looze C, et al. 2014. Antibiotic Stewardship in Orthopaedic Surgery: principles and Practice. J Am Acad Orthop Surg 22:772–781.
19. Binkley JM, Stratford PW, Lott SA, et al. 1999. The lower extremity functional scale (LEFS): scale development, measurement properties, and clinical application. north american orthopaedic rehabilitation research network. Phys Ther 79:371–383.
20. Ware J, Jr, Kosinski M, Keller SD. 1996. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 34:220–233.
21. Katz S, Downs TD, Cash HR, et al. 1970. Progress in development of the index of ADL. Gerontologist 10:20–30.
22. Stepanovic S, Vukovic D, Hola V, et al. 2007. Quantification of biofilm in microtiter plates: overview of testing conditions and practical recommendations for assessment of biofilm production by staphylococci. APMIS 115:891–899.
23. Montanaro L, Speziale P, Campoccia D, et al. 2011. Scenery of Staphylococcus implant infections in orthopedics. Future Microbiol 6:1329–1349.
24. Barsoumian AE, Mende K, Sanchez CJ, Jr, et al. 2015. Clinical infectious outcomes associated with biofilm-related bacterial infections: a retrospective chart review. BMC Infect Dis 15:223.
25. Akers KS, Mende K, Cheatle KA, et al. 2014. Biofilms and persistent wound infections in United States military trauma patients: a case-control analysis. BMC Infect Dis 14:190.
26. Rupp ME, Ulphani JS, Fey PD, et al. 1999. Characterization of the importance of polysaccharide intercellular adhesin/hemagglutinin of Staphylococcus epidermidis in the pathogenesis of biomaterial-based infection in a mouse foreign body infection model. Infect Immun 67:2627–2632.
27. Vuong C, Kocianova S, Voyich JM, et al. 2004. A crucial role for exopolysaccharide modification in bacterial biofilm formation, immune evasion, and virulence. J Biol Chem 279:54881–54886.
28. Schaeffer CR, Woods KM, Longo GM, et al. 2015. Accumulation-associated protein enhances Staphylococcus epidermidis biofilm formation under dynamic conditions and is required for infection in a rat catheter model. Infect Immun 83:214–226.
29. Kilgus DJ, Howe DJ, Strang A. 2002. Results of periprosthetic hip and knee infections caused by resistant bacteria. Clin Orthop Relat Res 116–124.
30. Salgado CD, Dash S, Cantey JR, et al. 2007. Higher risk of failure of methicillin-resistant Staphylococcus aureus prosthetic joint infections. Clin Orthop Relat Res 461:48–53.
31. Volin SJ, Hinrichs SH, Garvin KL. 2004. Two-stage reimplantation of total joint infections: a comparison of resistant and non-resistant organisms. Clin Orthop Relat Res 427:94–100.
32. Cardile AP, Sanchez CJ Jr., Samberg ME, et al. 2014. Human plasma enhances the expression of Staphylococcal microbial surface components recognizing adhesive matrix molecules promoting biofilm formation and increases antimicrobial tolerance In Vitro. BMC Res Notes 7:457.
33. Tunney MM, Patrick S, Curran MD, et al. 1999. Detection of prosthetic hip infection at revision arthroplasty by immunofluorescence microscopy and PCR amplification of the bacterial 16S rRNA gene. J Clin Microbiol 37:3281–3290.